Thank Investor Willoughby I like Relations. you good and Bryan President would Vice begin afternoon of to welcoming our everyone. by new as Steve
We to a on analyst of a have He real-time are Steve's and him to market pulse wealth join seem the of many you have industry as the knowledge, finger deep And excited trends. team. always brings of know, research industrial experience. surveys
during the of periods. are one yours frankly, I know I of to in living and new a a We transform looking that and XXXX to as and continue it months has first cliche, diagnostics ago. And expertise in organization. career a was is the quite week Stepping veteran was in forward PerkinElmer and my agility. life but regard living Success teamwork four to little suspect we were byproduct most insights into like compared XX felt too. rolling in XXXX. we class dynamic are his a we months changed and years of four world sciences grow back, It
keep core us toes. are markets improving, continues our COVID are things for to While certain. on Two our
bottom, to quarter stronger as the first tested Our team performance is a that COVID emerging and organization. from reinforces is PerkinElmer, top
incredibly our team throughout first respond innovating we to mindset world-class mission over putting and genuine a organization. challenges inspired kind the another We our make appreciate times collaboration continue will differentiate customer demonstrate the team have and I quickly remain resiliency, shown by dedication, to team. said for first a healthier impassions of and entire I the the our year, the beyond. customer of first cry that of can will in XXXX are And around XXXX countless and and PerkinElmer have We us world thrown compassion it and rallying one our agility, our way. whatever and for shined for but resonates of us PerkinElmer and past culture continuing to and world
And really commercial prouder. of recent not mission, financial a in Our and the commitment and be our success day to is team's byproduct driving could out. I
many and the Turning a momentum XX%, delivered free share we XXX% delivered recovery direct Adjusted an byproduct of the adjusted seeing COVID XXX% cash in simple. But earnings strategic end playbook broad-based flow outstanding most by start core across that conversion. performance. the encouraged has per we was people, the the against a by four sounds reinvigorated grew of underlying experienced to innovation are new revenue overall, are the our first detail to across PerkinElmer portfolio. the operational around financial and from to we back going is quarter organic ways, strong excellence. increased The will and respectively. results. truly our and organization. priorities, markets. pandemic our But Jamey PerkinElmer emerging I we execution it basics the the further know, and is go into Adjusted customers, XXX% conscious year
of launched Leadership in and their team and Officer we our in efforts. progress & our professional Four culture own her of accelerate made to first our external laser Culture of on a programs engage better areas On and Magali talent promoted term, invested the reinforcing tools and several bolstering beyond levels to in will all people Near become Specific quarter. for be transformation and as growth. work of the instituting resources over PerkinElmer's profile was course destination focused Magali employees choice the the front, to foundation, Academy and development, talent. top PerkinElmer People Chief we learning the caring recently to engagement
and managers direct empowering are of objectives as development teams increasingly that with reports and next Tracking our and engagement. individual we maintaining well goals ensuring remote pivotal generation employee accountable are in leaders. even to is Additionally, we for environments managing contact holding as and
around the video we world. both the efforts. inclusion DEI established local global recently equity of On example immediate team honor to inclusion a on and diversity, focus One creation and the been of a XXX The was Women's inclusion execute moving and board has great champions identified front, to an montage spearheading the over Day. International
to Looking accelerate outward, the momentum portfolio we innovation. increased and in continue reposition investments through
has toggle love seamless demand of that was on the the PerkinElmer. On a the COVID dynamics. since based to the further the XX% platform real-time by rate remains well fact north of tender competitive The throughput for platform August. best-in-class the front, reinforced and is differentiator explorer last workstation the workflow rabidly ability Customers remained launched nature win
we EUA normalization. anticipate the we the will the Additionally, COVID were PerkinElmer test individuals reopen. economies quarter uniquely for march during carriers help proud continues from in important receive as positioned remain the asymptomatic testing asymptomatic future. across surveillance to to for that FDA be And globe foreseeable target an to toward largely as the
cell an life we pool and the suppliers sensitive cellular the more laboratories. this for tests be to and which one unravel the diseases part novel have screening promote approach Outside painting to As new have computational responses. therapies to combines With as our new Cell reagents. them. biology PhenoVue powerful workflow, to treat and better content portfolio of cellular is of researchers understand cell able develop kit and sciences imaging time for maintain market capabilities which high most asymptomatic EUA a of will diagnostic to COVID, pinpointed groundbreaking PCR are painting end-to-end and testing testing, few saves reintroduced rapid on a resources team the of and
which which Consortium, The as Additionally, our length approved allow JUMP-Cell knockout all have research. launched more moderation exciting will studies. a repress reagents or during completely many new top well forging the these their the readouts pharmaceutical relationships. CRISPR any for acquired to any CRISPR time high rather Horizon existing to without From to researchers repress lines, well to Researchers expanding Broad throughput a flexibility new reagents on quarter. CRISPRi. and the customer an over CRISPRi were for in by Painting had global from team of for gene, gene crystal genes recently execute family cell the the business partnerships of Institute. as Discovery includes we Meanwhile, cut nuanced the of as standpoint, almost is Interference as at scale use continue a own companies single announcement of allowing recently than
for XX the win level technical selected to warning environmental date added around PerkinElmer systems. with distributed During new in in another as where to total, new were tender and will instruments as new the hazardous safety XX improve municipalities America. LC is our a a The And centers we quarter, is order lab seminal India. first we the approximately testing supplier XXX was exciting event and sizeable of capabilities and early be several CDC ingredients. nine largest platform country the to it the In Europe and testing. Vanadis franchise to food province in established largest We support North both relationships. Yunnan Vanadis UHPLC we and XX which is examples forge customers for the
emerging growing substantive more quarters. the provide is time, momentum the experience to from due several platform but COVID a with will strong funnel a accelerating in We position on great over pipeline, and updates Vanadis next in
Discovery, stronger two my on I prepared The years that than new earlier is of PerkinElmer Horizon recently position. from ago. is further Omni Immunotec and remarks, Oxford most bolsters COVID in addition As the said much emerging a footing our
areas in year-over-year. quarter, out in contributors grew high-growth future. assets opportunity combined these XX% three the where the importantly, But inorganic While over during see we significant new three carve niches all first more
already Horizon engaged the workflow. well. very Specifically, commercial begun has quarter. integration driving early scale their screening Horizon automated actively some and the And team workflows teams applied and automation to to and our wins. capabilities highly Discovery phenomenally efforts. Both leverage executed commercial technology PerkinElmer's differentiated COVID-XX enhance engineering is proceeding during PerkinElmer critical component Meanwhile, the line test cell The internal are homogenization PerkinElmer's in has food has been also mill the Omni's process are markets. cannabis complementary potential with saliva in International's And a it end-to-end to portfolio. Omni bead genomics
wins. quickly Lastly, a the early account into revenue months are wins automation to only on PerkinElmer. team small for be out both on The new visibility more impact synergy is several In of progress recent Immunotec has of already excited an the and closing, build cost integration and rollout the on momentum. on Oxford executed the on future and eager about not continues the organization our while couple improve. gate we could opportunities The I to having energized is efforts,
transformed positioned to of tomorrow. have we and opportunities fundamentally ourselves undoubtedly the capture We are better
faster into have core market solutions further novel markets. investing We deliver markets stronger our to scale portfolio our and to a in expand to to leveraging where we proactively successfully growing right are the win, and augment
our We are take gas. not going to off foot the
behind second we COVID our growth quarter in another I to we the up quarter well on to our PerkinElmer shaping be into XX% outstanding XX. core what plan announce on positioned the further to with Investors grow guided businesses on encourage point, to XXXX analyst of going to go than scenes and The after organic pre-register. are has we Day the June and quarter at that to that I a website excited ago. everyone call been And am to delve both upcoming section faster to our during
can Having India call moment India, company which security day. take our X,XXX devastating the lives to role the the PerkinElmer, situation over is I taking our a in both a comment home. want we present in I thousands do that in on help the global for over COVID-XX situation truly At employees been that a of that turn as to working of citizen to hits to is every and and we country. the it employs Before the born Jamey, country, everything locally and feel
facilitate both employees companies medical including and providing working way, and meeting vaccination officials in provide the in support services. U.S. seeking around We and urgent have drives, India possible the to team India to and other U.S. their in assist every vital joined government testing to goods needs. Locally, our is organizing our clock engaged
heart to countless world, the go post-COVID While and looking are are prayers still many to everyone around with daily transition the My globe promise will tirelessly and to struggling pandemic countries curve. still PerkinElmer, their are in and at afflicted with and and support I who combat COVID-XX flatten daily to the dealing efforts we acutely continue regions the Jamey? a impact. out its people eagerly others deadly pandemic that
